First report of a medullar cord compression secondary to osseous plasmacytoma successfully treated with bortezomib and dexamethasone

Leuk Res. 2010 Apr;34(4):e97-9. doi: 10.1016/j.leukres.2009.09.029.

Abstract

Medullar cord compression secondary to osseous plasmacytomas affecting the vertebrae is an oncological emergency. A 75-year-old woman with recurrent osseous plasmacytomas and thoracic spinal cord compression, previously treated with radiotherapy, was successfully treated with bortezomib and dexamethasone. Three years later, when the plasmacytoma and spinal cord compression relapsed, she was retreated with the same therapeutic scheme, achieving a new complete clinical remission. This is the first reported case of an excellent response to the combination of bortezomib and dexamethasone for spinal cord compression due to osseous plasmacytoma.

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Bone Neoplasms / complications
  • Bone Neoplasms / diagnosis
  • Bone Neoplasms / drug therapy*
  • Boronic Acids / administration & dosage
  • Bortezomib
  • Dexamethasone / administration & dosage
  • Female
  • Humans
  • Middle Aged
  • Plasmacytoma / complications
  • Plasmacytoma / diagnosis
  • Plasmacytoma / drug therapy*
  • Pyrazines / administration & dosage
  • Spinal Cord Compression / diagnosis
  • Spinal Cord Compression / drug therapy*
  • Spinal Cord Compression / etiology
  • Treatment Outcome

Substances

  • Boronic Acids
  • Pyrazines
  • Bortezomib
  • Dexamethasone